Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

Xth Eurasian Hematology-Oncology Congress
D

Should ALL Treatment be Driven by MRD Detection? IOs Result in Higher MRD vs. Chemo, Frontline IO May Alter Treatment Paradigm

By Xth Eurasian Hematology-Oncology Congress FEATURING Dieter Hoelzer
By Xth Eurasian Hematology-Oncology Congress FEATURING Dieter Hoelzer
24 views
December 13, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Hematologic Oncology
10:05

Best Abstract Presentation (Francesco Lo Coco Prize) - Adult Hematol…

Xth Eurasian Hematology-Oncology Congress

M. Ozbalak

28 views
07:09

Best Abstract Presentation (Ekrem Muftuoglu Prize) - Oncology Evalua…

Xth Eurasian Hematology-Oncology Congress

S. Çelik

10 views
10:30

Best Abstract Presentation (Atilla Yalcin Prize) - Transplant Is The…

Xth Eurasian Hematology-Oncology Congress

P. Kaloyannidis

7 views
21:36

How I Treat Multiple Myeloma

Xth Eurasian Hematology-Oncology Congress

A. Maiolino

94 views
22:57

Importance of MRD in Multiple Myeloma: Can MRD Guide Therapy in Newl…

Xth Eurasian Hematology-Oncology Congress

E. Terpos

16 views
18:10

Impact of Continuous First-Line Therapy in the Treatment of the Firs…

Xth Eurasian Hematology-Oncology Congress

A. Ibrahim

45 views
23:38

Therapeutic Modulation of The Pleural Effusion Environment: the Next…

Xth Eurasian Hematology-Oncology Congress

V. Donnenberg

18 views
18:57

The Secretome of Malignant Effusions: The IL-6/sIL-6Ra Axis Appears …

Xth Eurasian Hematology-Oncology Congress

A. Donnenberg

23 views
24:57

Are Maintenance Post-transplant Therapies Needed: Hypomethylating Ag…

Xth Eurasian Hematology-Oncology Congress

K. Halahleh

27 views
20:18

Will CAR T-cell Therapy Replace HSCT? The Use of CAR-T Could Further…

Xth Eurasian Hematology-Oncology Congress

F. Saglio

31 views
25:14

Oral Chronic GVHD Is Common Disease and May Persist for Years, Manag…

Xth Eurasian Hematology-Oncology Congress

N. Treister

29 views
10:40

Analysis of PFS in CLL: Pts Who Received First-Line Bendamustine-Rit…

Xth Eurasian Hematology-Oncology Congress

I. Miroliubova

16 views
11:45

Prognostic Implication of NOTCH 1 Expression Among Adult Patients wi…

Xth Eurasian Hematology-Oncology Congress

G. Elyamany

12 views
16:28

2019 SOHO Update on AML: FLT3 and IDH1/2 Inhibitors, Venetoclax, Ant…

Xth Eurasian Hematology-Oncology Congress

G. Garcia-Manero

201 views
21:46

Personalizing Prognosis and Treatment of MPN: Historical Milestones …

Xth Eurasian Hematology-Oncology Congress

T. Mughal

25 views
23:03

The Best Example of Precision Oncology in CML: Response to TKI Thera…

Xth Eurasian Hematology-Oncology Congress

G. Saglio

89 views
22:56

Precision Oncology in MDS: We Still Don't Know Precise Mechanism of …

Xth Eurasian Hematology-Oncology Congress

M. Çetiner

22 views
15:40

2019 SOHO Update on ALL: Ponatinib -Blinatumomab in Ph+, Ino / Blina…

Xth Eurasian Hematology-Oncology Congress

E. Jabbour

111 views
14:17

2019 SOHO Updates on CML: Frontline Therapy is Good, Getting Better …

Xth Eurasian Hematology-Oncology Congress

E. Jabbour

152 views
19:17

2019 SOHO Updates on MDS: Treatment of CHIP, New Approach for Anemia…

Xth Eurasian Hematology-Oncology Congress

G. Garcia-Manero

45 views
16:04

St-Petersburg Hematological Centre Experience on the Use of BMT in R…

Xth Eurasian Hematology-Oncology Congress

N. Mikhailova

27 views
14:22

Kirov Hematological Institute Analysis of Donors Register: Unrelated…

Xth Eurasian Hematology-Oncology Congress

M. Loginova

7 views
13:40

Bone Marrow Allogenic Transplantation in Relapsed/ Refractory Hem Ma…

Xth Eurasian Hematology-Oncology Congress

I. Moiseev

16 views
20:34

Should ALL Treatment be Driven by MRD Detection? IOs Result in Highe…

Xth Eurasian Hematology-Oncology Congress

D. Hoelzer

24 views
20:45

2019 Therapy of Ph+ ALL: Which TKIs, Dosing and Schedule, Intensity,…

Xth Eurasian Hematology-Oncology Congress

O. Ottmann

104 views
12:21

Ph-like ALL Should Be Treated as the Other B ALL After Demonstration…

Xth Eurasian Hematology-Oncology Congress

O. Ottmann

19 views
24:55

Overview of Current Therapeutic Options in AML of Young Adults: New …

Xth Eurasian Hematology-Oncology Congress

M. Yilmaz

189 views
22:53

Risk Stratification and Treatment of CLL: If New Drugs Available, 17…

Xth Eurasian Hematology-Oncology Congress

R. Foa

241 views
22:05

Therapeutic Approach for CLL Biomarkers: Low-Risk Should Be Treated …

Xth Eurasian Hematology-Oncology Congress

P. Panayiotidis

227 views
22:53

New Drugs Have an Established Role in CLL: BCR and BCL2 Inhibitors (…

Xth Eurasian Hematology-Oncology Congress

R. Foa

211 views
13:19

Moscow National Hematological Centre Experience on the Role and Plac…

Xth Eurasian Hematology-Oncology Congress

L. Mendeleeva, M. Solovev

7 views
07:20

Ph-like ALL Therapy Should Be Different From the Other B-ALL: Target…

Xth Eurasian Hematology-Oncology Congress

D. Hoelzer

19 views
23:09

Hemostasis Changes in Paroxysmal Nocturnal Hemoglobinuria: Is PNH a …

Xth Eurasian Hematology-Oncology Congress

P. Toulon

29 views
26:52

Managing Paroxysmal Nocturnal Hemoglobinuria: Chronic Complement-Med…

Xth Eurasian Hematology-Oncology Congress

B. Antmen

52 views
21:11

Eosinophilia and Mastocytosis: TKIs are SOC for PDGFRa/b Mutations, …

Xth Eurasian Hematology-Oncology Congress

H. Hamed

22 views
19:25

Approaching Consensus in Immune Thrombocytopenic Purpura: Adult ITP …

Xth Eurasian Hematology-Oncology Congress

D. Provan

22 views